| Todd Templeman, MD | |
|
110 Irving St Nw, Suite Na-1177, Washington, DC 20010-3017 | |
| (202) 877-7632 | |
| (202) 877-2468 |
| Full Name | Todd Templeman |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 110 Irving St Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003831496 | NPI | - | NPPES |
| P00706333 | Other | DC | MEDICARE RAILROAD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 036-112118 (Illinois) | Secondary |
| 207P00000X | Emergency Medicine | MD036599 (District Of Columbia) | Primary |
| Entity Name | Bethesda Emergency Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639125941 PECOS PAC ID: 4880581297 Enrollment ID: O20040301001187 |
News Archive
Alkermes, Inc. today announced the initiation of a multidose phase 1 clinical study of ALKS 37, an orally active, peripherally-restricted opioid antagonist with potential to block the effects of opioid agonists on gastrointestinal motility, commonly referred to as opioid-induced constipation (OIC). The randomized, double-blind, placebo-controlled, repeat-dose study will assess the safety, tolerability and pharmacokinetics of daily oral administration of two dose levels of ALKS 37 for a seven day period in approximately 24 healthy volunteers.
Advanced Medical Isotope Corporation, a company engaged in the production and distribution of medical isotopes, is delighted to announce the execution of an exclusive world-wide license for patented technology for a proprietary brachytherapy seed with a fast-dissolving matrix for optimized delivery of radionuclides to cancer tissue.
Egalet Corporation today reported financial results for the year ended December 31, 2014.
Sunovion Pharmaceuticals Canada Inc., formerly Sepracor Pharmaceuticals, Inc., today announced that the New Drug Submission (NDS) for Lurasidone HCl, for the treatment of adult patients with schizophrenia has been accepted for review by Health Canada. The NDS was submitted to Health Canada in June 2011 and will receive a standard review.
A Dartmouth-led study using a 600-year-old ice core shows that global mercury pollution increased dramatically during the 20th century, but that mercury concentrations in the atmosphere decreased faster than previously thought beginning in the late 1970s when emissions started to decline.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Todd Templeman, MD 110 Irving St Nw, Suite Na-1177, Washington, DC 20010-3017 Ph: (202) 877-7632 | Todd Templeman, MD 110 Irving St Nw, Suite Na-1177, Washington, DC 20010-3017 Ph: (202) 877-7632 |
News Archive
Alkermes, Inc. today announced the initiation of a multidose phase 1 clinical study of ALKS 37, an orally active, peripherally-restricted opioid antagonist with potential to block the effects of opioid agonists on gastrointestinal motility, commonly referred to as opioid-induced constipation (OIC). The randomized, double-blind, placebo-controlled, repeat-dose study will assess the safety, tolerability and pharmacokinetics of daily oral administration of two dose levels of ALKS 37 for a seven day period in approximately 24 healthy volunteers.
Advanced Medical Isotope Corporation, a company engaged in the production and distribution of medical isotopes, is delighted to announce the execution of an exclusive world-wide license for patented technology for a proprietary brachytherapy seed with a fast-dissolving matrix for optimized delivery of radionuclides to cancer tissue.
Egalet Corporation today reported financial results for the year ended December 31, 2014.
Sunovion Pharmaceuticals Canada Inc., formerly Sepracor Pharmaceuticals, Inc., today announced that the New Drug Submission (NDS) for Lurasidone HCl, for the treatment of adult patients with schizophrenia has been accepted for review by Health Canada. The NDS was submitted to Health Canada in June 2011 and will receive a standard review.
A Dartmouth-led study using a 600-year-old ice core shows that global mercury pollution increased dramatically during the 20th century, but that mercury concentrations in the atmosphere decreased faster than previously thought beginning in the late 1970s when emissions started to decline.
› Verified 2 days ago
Emily Jean Siegel, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-8080 | |
James A. D'orta, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1700 Pennsylvania Ave Nw, Suite 550, Washington, DC 20006 Phone: 202-955-0000 | |
Guenevere Vanessa Burke, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 50 Irving St Nw, Washington, DC 20422 Phone: 202-741-3581 | |
Jennifer Yu, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, C/o Surgical Critical Care Services, Washington, DC 20010 Phone: 202-877-7000 | |
Diane A Sauter, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3800 Reservoir Rd Nw, Washington, DC 20007 Phone: 202-444-2119 | |
Namman N Halabi, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1150 Varnum St Ne, Washington, DC 20017 Phone: 202-269-7000 |